Michael Myers

Bio:

Mike has 38 years of pharma industry experience and worked across both Drug Discovery and Drug Development areas.  His last role at Eli Lilly & Co was in leading scientific & technical due diligence for the enterprise.

After retiring from Lilly in mid-2025, Mike launched ID4 Consulting and is now engaged in advising Biotech's on Drug Discovery & Development, Project Management and BD activities. Mike also has an adjunct appointment at the IU School of Medicine and supports Indiana’s NIH-funded CTSI Initiative.